p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.

p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.
复制标题

p70S6K促进IL-6诱导的头颈鳞癌上皮间质转化和转移

DOI:
10.18632/oncotarget.9282
复制
发表时间:
2016-06-14
期刊:
影响因子:
--
通讯作者:
Wang X
Wang X
中科院分区:
其他
文献类型:
--
作者:
Wu D;Cheng J;Sun G;Wu S;Li M;Gao Z;Zhai S;Li P;Su D;Wang X

文献摘要

参考文献

相似文献

头颈部鳞状细胞癌(HNSCC)是全球第五大常见癌症,也是癌症相关死亡的常见原因,5年生存率低于60%。IL-6在肿瘤转移中起重要作用,但其在HNSCC中的作用机制尚未完全阐明。p70 S6 K可诱导卵巢癌的上皮间质转化(EMT),但其在HNSCC中的作用尚不清楚。在这项研究中,我们发现,p70 S6 K和IL-6在高转移HNSCC细胞系进行EMT时,与配对的低转移细胞系相比,上调。p70 S6 K过表达促进HNSCC细胞的EMT和迁移,而下调p70 S6 K则减弱IL-6诱导的EMT和细胞迁移。此外,IL-6诱导的p70 S6 K激活被PI 3 K/Akt/mTOR、MAPK/ERK和JAK/STAT 3信号通路的抑制剂减弱,表明其位于这些通路的下游。提示p70 S6 K促进IL-6诱导的HNSCC EMT和转移。靶向p70 S6 K用于HNSCC治疗可以通过抑制肿瘤生长以及转移而使患者受益。
Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer worldwide and a common cause of cancer-related death, with a 5-year survival rate of less than 60%. IL-6 has been suggested to play an important role in cancer metastasis, but its mechanism in HNSCC has not been fully clarified. p70S6K has been reported to induce epithelial-mesenchymal transition (EMT) of ovarian cancer, but its role in HNSCC remains unknown. In this study, we found that p70S6K and IL-6 were upregulated in high-metastatic HNSCC cell lines that underwent EMT when compared to paired low-metastatic cell lines. Overexpression of p70S6K promoted EMT and migration of HNSCC cells, while downregulation of p70S6K attenuated IL-6-induced EMT and cell migration. Furthermore, IL-6-induced p70S6K activation was attenuated by inhibitors of the PI3K/Akt/mTOR, MAPK/ERK, and JAK/STAT3 signaling pathways, suggesting that it located downstream of these pathways. These findings suggest that p70S6K promotes IL-6-induced EMT and metastasis of HNSCC. Targeting p70S6K for HNSCC therapy may benefit patients through the inhibition of tumor growth, as well as metastasis.
AEG-1 是哌立福辛的靶标,在胃发育不良和癌症中过度表达
DOI: 10.1007/s10620-013-2735-5
发表时间: 2013-10-01
影响因子: 3.1
作者:
Huang, Wenbin;Yang, Li;Wang, Xuerong
通讯作者: Wang, Xuerong
DOI: 10.1002/ijc.29558
发表时间: 2015-10-15
影响因子: 6.4
作者:
Gaykalova DA;Manola JB;Ozawa H;Zizkova V;Morton K;Bishop JA;Sharma R;Zhang C;Michailidi C;Considine M;Tan M;Fertig EJ;Hennessey PT;Ahn J;Koch WM;Westra WH;Khan Z;Chung CH;Ochs MF;Califano JA
通讯作者: Califano JA
针对抗性急性髓样白血病的新型信号通路。
DOI: 10.1016/j.ymgme.2014.11.017
发表时间: 2015-03
影响因子: 3.8
作者:
Sakamoto, Kathleen M.;Grant, Steven;Saleiro, Diana;Crispino, John D.;Hijiya, Nobuko;Giles, Francis;Platanias, Leonidas;Eklund, Elizabeth A.
通讯作者: Eklund, Elizabeth A.
DOI: 10.1002/ijc.23324
发表时间: 2008-05-01
影响因子: 6.4
作者:
Lee, Tin Lap;Yeh, Jason;Chen, Zhong
通讯作者: Chen, Zhong
DOI: 10.4161/cbt.20989
发表时间: 2012-09-01
影响因子: 3.6
作者:
Ma, Zhuo;Zhu, Lingjun;Wang, Xuerong
通讯作者: Wang, Xuerong